Table 1.
Criteria for setting priorities according to their assessed importance by participants and external stakeholders.
| Domain | Items | Mean participants' weighted score (SD) |
|---|---|---|
| Disease Burden | - Disease/Condition incidence or prevalence - High risk impact of disease/condition in the health system - High frequency of risk factors associated with the disease/condition - High frequency of avoidable risk factors associated with the disease/condition |
80,8 (18,2) |
| Information needs in the Health Sector | - Information needs within the Institution/Organization - Current controversy about topic importance - High importance of new methods and technology assessment - Fast diffusion of non-assessed technologies, availability of resources and sufficient time for technologies implementation - Country health priorities in agreement with CPG's needs - High impact on national health system |
74,7 (18,1) |
| Feasibility on development and implementation | - Feasibility on recommendations development which will improve health outcomes and cost - Is the proposal politically feasible? - Does it belong to priority health areas according to government policies? - Feasibility in implementation; will not require an excessive amount of resources and will not present important barriers to implement changes - Will reduce inequities when implemented - Will require education to training professionals - Does the proposed topic include the participation of multiple departments, institutions, organizations, etc? |
72,7 (17,1) |
| Effectiveness | - Availability of effective methods shown by methodologically adequate studies. - Certainty about effectiveness of assessed interventions and technologies - Potential impact of CPG |
71,2 (20,7) |
| Economic impact on the health system | - Economic effects on health system (cost of an individual patient is high during diagnosis or therapeutic process) - Disease/Condition associated with iatrogenic interventions that are significantly high in cost. |
69,8 (24,0) |
| Clinical Practice Variation | - Current evidence is insufficient for disease control in the population - Lack of high quality CPGs - Availability of high volume of evidence regarding the CPG topic - Evidence of inappropriate use of available technologies used in the treatment of condition (iatrogenic) - Conditions/diseases where effective treatments could reduce mortality or morbidity - Evidence of disagreements between current treatment and literature recommendations. |
68,0 (22,1) |
| Other social effects/Equity | - Absenteeism from work or school, inability to work, inequities in access to health services - Will the service be available to anyone who requires it? - Will this CPG have a positive or negative impact on minorities' access to health services? - Will the CPG increase health service access to those affected by the condition? |
67,2 (25,7) |
| User Preferences | - High patient demand or interest - Concerns about patients' quality of life - Feasibility of patient empowerment - High acceptability of the topic between the general public and professionals affected by the use of the CPG. |
64,9 (22,3) |
| Adverse events | - Possibility of adverse events - Possibility of serious adverse events - Disease/condition associated with high incidence of adverse events or sequels |
57,1 (28,0) |
| Health Promotion and Disease Prevention | - Feasibility of prevention between patients with risk factors - Are there specific activities of health promotion, disease prevention, early diagnosis or treatment? Have all of them shown a reduction in disease burden? |
56,4 (32,3) |
* The maximum score was 100 and the minimum was 0